Skye Bioscience, Inc. Increase (Decrease) in Employee Related Liabilities
Skye Bioscience, Inc. (SKYE) reported Increase (Decrease) in Employee Related Liabilities of -$578.91 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities · last filed 2026-08-14
- Skye Bioscience, Inc. increase (decrease) in employee related liabilities for the quarter ending 2026-06-30 was $456.17K, a 115.29% increase year-over-year.
- Skye Bioscience, Inc. increase (decrease) in employee related liabilities for the quarter ending 2026-03-31 was -$1.04M.
- Skye Bioscience, Inc. increase (decrease) in employee related liabilities for the quarter ending 2025-12-31 was $348.70K, a 65.27% increase year-over-year.
- Skye Bioscience, Inc. increase (decrease) in employee related liabilities for the quarter ending 2025-09-30 was $52.75K, a 84.78% decline year-over-year.
- Skye Bioscience, Inc. increase (decrease) in employee related liabilities for fiscal 2025 was $155.22K, a 31.28% decline from fiscal 2024.
- Skye Bioscience, Inc. increase (decrease) in employee related liabilities for fiscal 2024 was $225.87K, a 2.07% decline from fiscal 2023.
- Skye Bioscience, Inc. increase (decrease) in employee related liabilities for fiscal 2023 was $230.65K, a 26.38% decline from fiscal 2022.
- Skye Bioscience, Inc. increase (decrease) in employee related liabilities for fiscal 2022 was $313.28K, a 10.74% increase from fiscal 2021.
| Period end | Increase (Decrease) in Employee Related Liabilities 3 month | Increase (Decrease) in Employee Related Liabilities 6 month | Increase (Decrease) in Employee Related Liabilities 6 month as first filed | Increase (Decrease) in Employee Related Liabilities 9 month | Increase (Decrease) in Employee Related Liabilities 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $456.17K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$578.91K 10-Q · filed 2026-08-14 | -$230.21K derived: sum of 3 quarters · filed 2026-08-14 | -$177.46K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | -$1.04M 10-Q · filed 2026-05-11 | -$686.38K derived: sum of 2 quarters · filed 2026-05-11 | -$633.63K derived: sum of 3 quarters · filed 2026-05-11 | -$421.74K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-12-31 | $348.70K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $401.45K derived: sum of 2 quarters · filed 2026-03-10 | $613.34K derived: sum of 3 quarters · filed 2026-08-14 | $155.22K 10-K · filed 2026-03-10 | |
| 2025-09-30 | $52.75K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $264.64K derived: sum of 2 quarters · filed 2026-08-14 | -$193.48K 10-Q · filed 2025-11-10 | $17.50K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-06-30 | $211.89K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$246.23K 10-Q · filed 2026-08-14 | -$35.25K derived: sum of 3 quarters · filed 2026-08-14 | $311.45K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | -$458.12K 10-Q · filed 2026-05-11 | -$247.14K derived: sum of 2 quarters · filed 2026-05-11 | $99.56K derived: sum of 3 quarters · filed 2026-05-11 | $302.67K derived: sum of 4 quarters · filed 2026-05-11 | |
| 2024-12-31 | $210.99K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $557.68K derived: sum of 2 quarters · filed 2026-03-10 | $760.79K derived: sum of 3 quarters · filed 2026-03-10 | $225.87K 10-K · filed 2026-03-10 | |
| 2024-09-30 | $346.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $549.81K derived: sum of 2 quarters · filed 2025-11-10 | $14.89K 10-Q · filed 2025-11-10 | $257.44K derived: sum of 4 quarters · filed 2025-11-10 | |
| 2024-06-30 | $203.11K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$331.81K 10-Q · filed 2025-08-07 | -$89.26K derived: sum of 3 quarters · filed 2025-08-07 | -$357.36K derived: sum of 4 quarters · filed 2025-08-07 | |
| 2024-03-31 | -$534.92K 10-Q · filed 2025-05-08 | -$292.37K derived: sum of 2 quarters · filed 2025-05-08 | -$560.47K derived: sum of 3 quarters · filed 2025-05-08 | -$439.04K derived: sum of 4 quarters · filed 2025-05-08 | |
| 2023-12-31 | $242.55K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$25.55K derived: sum of 2 quarters · filed 2025-03-20 | $95.88K derived: sum of 3 quarters · filed 2025-03-20 | $230.65K 10-K · filed 2025-03-20 | |
| 2023-09-30 | -$268.10K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$146.67K derived: sum of 2 quarters · filed 2024-11-07 | -$11.90K 10-Q · filed 2024-11-07 | $201.85K derived: sum of 4 quarters · filed 2024-11-07 | |
| 2023-06-30 | $121.43K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $256.19K 10-Q · filed 2024-08-09 | $256.20K 10-Q · filed 2023-08-07 | $469.95K derived: sum of 3 quarters · filed 2024-08-09 | $563.68K derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | $134.77K 10-Q · filed 2024-05-10 | $348.52K derived: sum of 2 quarters · filed 2024-05-10 | $442.25K derived: sum of 3 quarters · filed 2024-05-10 | $555.46K derived: sum of 4 quarters · filed 2024-05-10 | |
| 2022-12-31 | $213.75K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $307.49K derived: sum of 2 quarters · filed 2024-03-22 | $420.70K derived: sum of 3 quarters · filed 2024-03-22 | $313.28K 10-K · filed 2024-03-22 | |
| 2022-09-30 | $93.73K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $206.95K derived: sum of 2 quarters · filed 2023-11-14 | $99.53K 10-Q · filed 2023-11-14 | $181.10K derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | $113.21K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $5.80K 10-Q · filed 2023-08-07 | $87.37K derived: sum of 3 quarters · filed 2023-08-07 | $237.74K derived: sum of 4 quarters · filed 2023-08-07 | |
| 2022-03-31 | -$107.41K 10-Q · filed 2023-05-12 | -$25.84K derived: sum of 2 quarters · filed 2023-05-12 | $124.53K derived: sum of 3 quarters · filed 2023-05-12 | $105.04K derived: sum of 4 quarters · filed 2023-05-12 | |
| 2021-12-31 | $81.57K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $231.94K derived: sum of 2 quarters · filed 2023-03-31 | $212.46K derived: sum of 3 quarters · filed 2023-03-31 | $282.90K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $150.37K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $130.89K derived: sum of 2 quarters · filed 2022-11-14 | $201.33K 10-Q · filed 2022-11-14 | $201.33K derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | -$19.49K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $50.96K 10-Q · filed 2022-08-15 | $50.96K derived: sum of 3 quarters · filed 2022-08-15 | -$144.02K derived: sum of 4 quarters · filed 2022-08-15 | |
| 2021-03-31 | $70.45K 10-Q · filed 2022-05-06 | $70.45K derived: sum of 2 quarters · filed 2022-05-06 | -$124.53K derived: sum of 3 quarters · filed 2022-05-06 | $94.99K derived: sum of 4 quarters · filed 2022-05-06 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | -$194.98K derived: sum of 2 quarters · filed 2022-03-28 | $24.55K derived: sum of 3 quarters · filed 2022-03-28 | $0.00 10-K · filed 2022-03-28 | |
| 2020-09-30 | -$194.98K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $24.55K derived: sum of 2 quarters · filed 2021-11-10 | $0.00 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $219.53K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $194.98K 10-Q · filed 2021-08-06 | |||
| 2020-03-31 | -$24.55K 10-Q · filed 2021-05-07 | ||||
| 2019-12-31 | $10.00K 10-K · filed 2020-03-23 | ||||
| 2019-03-31 | -$9.55K 10-Q · filed 2019-05-10 | $8.22K derived: sum of 2 quarters · filed 2019-05-10 | -$1.66K derived: sum of 3 quarters · filed 2019-05-10 | $10.96K derived: sum of 4 quarters · filed 2019-05-10 | |
| 2018-12-31 | $17.77K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $7.89K derived: sum of 2 quarters · filed 2019-03-14 | $20.51K derived: sum of 3 quarters · filed 2019-03-14 | $11.70K 10-K · filed 2019-03-14 | |
| 2018-09-30 | -$9.89K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $2.73K derived: sum of 2 quarters · filed 2018-11-14 | -$6.07K 10-Q · filed 2018-11-14 | -$397.06K derived: sum of 4 quarters · filed 2019-05-10 | |
| 2018-06-30 | $12.62K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | $3.81K 10-Q · filed 2018-08-10 | -$387.17K derived: sum of 3 quarters · filed 2019-05-10 | -$223.84K derived: sum of 4 quarters · filed 2019-05-10 | |
| 2018-03-31 | -$8.81K 10-Q · filed 2019-05-10 | -$399.79K derived: sum of 2 quarters · filed 2019-05-10 | -$236.46K derived: sum of 3 quarters · filed 2019-05-10 | -$73.27K derived: sum of 4 quarters · filed 2019-05-10 | |
| 2017-12-31 | -$390.99K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | -$227.65K derived: sum of 2 quarters · filed 2019-03-14 | -$64.46K derived: sum of 3 quarters · filed 2019-03-14 | -$112.83K 10-K · filed 2019-03-14 | |
| 2017-09-30 | $163.33K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $326.53K derived: sum of 2 quarters · filed 2018-11-14 | $278.16K 10-Q · filed 2018-11-14 | $373.70K derived: sum of 4 quarters · filed 2018-11-14 | |
| 2017-06-30 | $163.20K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | $114.83K 10-Q · filed 2018-08-10 | $210.36K derived: sum of 3 quarters · filed 2018-08-10 | $247.58K derived: sum of 4 quarters · filed 2018-08-10 | |
| 2017-03-31 | -$48.37K 10-Q · filed 2018-05-15 | $47.17K derived: sum of 2 quarters · filed 2018-05-15 | $84.39K derived: sum of 3 quarters · filed 2018-05-15 | $92.32K derived: sum of 4 quarters · filed 2018-05-15 | |
| 2016-12-31 | $95.53K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-19 | $132.75K derived: sum of 2 quarters · filed 2018-03-19 | $140.69K derived: sum of 3 quarters · filed 2018-03-19 | $121.07K 10-K · filed 2018-03-19 | |
| 2016-09-30 | $37.22K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $45.15K derived: sum of 2 quarters · filed 2017-11-14 | $25.53K 10-Q · filed 2017-11-14 | -$72.92K derived: sum of 4 quarters · filed 2017-11-14 | |
| 2016-06-30 | $7.93K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | -$11.68K 10-Q · filed 2017-08-11 | -$110.14K derived: sum of 3 quarters · filed 2017-08-11 | -$93.38K derived: sum of 4 quarters · filed 2017-08-11 | |
| 2016-03-31 | -$19.62K 10-Q · filed 2017-05-12 | -$118.07K derived: sum of 2 quarters · filed 2017-05-12 | -$101.31K derived: sum of 3 quarters · filed 2017-05-12 | -$82.26K derived: sum of 4 quarters · filed 2017-05-12 | |
| 2015-12-31 | -$98.45K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | -$81.69K derived: sum of 2 quarters · filed 2017-03-10 | -$62.64K derived: sum of 3 quarters · filed 2017-03-10 | $702.00 10-K · filed 2017-03-10 | |
| 2015-09-30 | $16.76K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $35.81K derived: sum of 2 quarters · filed 2016-11-09 | $99.16K 10-Q · filed 2016-11-09 | ||
| 2015-06-30 | $19.05K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12 | $82.39K 10-Q · filed 2016-08-12 | |||
| 2015-03-31 | $63.34K 10-Q · filed 2016-05-13 | ||||
| 2014-12-31 | $45.57K 10-K · filed 2016-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |